Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Article

Rolfo, Christian, Mack, Philip, Scagliotti, Giorgio V et al. (2021). Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer . RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 16(10), 1647-1662. 10.1016/j.jtho.2021.06.017

cited authors

  • Rolfo, Christian; Mack, Philip; Scagliotti, Giorgio V; Aggarwal, Charu; Arcila, Maria E; Barlesi, Fabrice; Bivona, Trever; Diehn, Maximilian; Dive, Caroline; Dziadziuszko, Rafal; Leighl, Natasha; Malapelle, Umberto; Mok, Tony; Peled, Nir; Raez, Luis E; Sequist, Lecia; Sholl, Lynette; Swanton, Charles; Abbosh, Chris; Tan, Daniel; Wakelee, Heather; Wistuba, Ignacio; Bunn, Rebecca; Freeman-Daily, Janet; Wynes, Murry; Belani, Chandra; Mitsudomi, Tetsuya; Gandara, David

authors

publication date

  • September 21, 2021

webpage

published in

keywords

  • AMERICAN-SOCIETY
  • CELL-FREE-DNA
  • CEREBROSPINAL-FLUID
  • CIRCULATING TUMOR DNA
  • CLINICAL-ONCOLOGY
  • EGFR
  • IASLC
  • Immunotherapy
  • Life Sciences & Biomedicine
  • Liquid biopsy
  • MOLECULAR TESTING GUIDELINE
  • MUTATIONAL BURDEN
  • NSCLC
  • Oncogene addicted
  • PLASMA
  • Pharmacology & Pharmacy
  • Public, Environmental & Occupational Health
  • Science & Technology
  • TYROSINE KINASE INHIBITORS
  • ctDNA

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1647

end page

  • 1662

volume

  • 16

issue

  • 10